144Filing Date: Oct 7, 2026
Resmed (RMD) 144: Farrell Michael J. plans to sell 4,991 Common ($1.1M) (Oct 7, 2026)
Insider Proposed Sale Notice
View SEC Filing
ACC: 0001959173-26-007310
Sale Plan
Farrell Michael J.
Officer, Director·Resmed
Proposed
CommonNYSE
Shares4.99K
Est. DateOct 7
Market Value$1.13M
BrokerFidelity Brokerage Services LLC
AcquisitionStock Option Exercise · Issuer
Acquired DateOct 7, 2026
Amount Acquired4.99K
10b5-1 Plan Adoption10/31/2024
% Outstanding0.0035%
10b5-1
Exercise / Payment Details
Paid: Oct 7, 2026Method: Cash
Sales Past 3 Months Total $3.23M · 14.97K sh. expand_more
Sep
8
$1.11M
4.99K sh.
Aug
7
$1.03M
4.99K sh.
Jul
7
$1.09M
4.99K sh.
Signature & Compliance expand_more
Notice DateOct 7, 2026
10b5-1 Plan Adoption10/31/2024
Signature /s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Farrell.
Issuer Info expand_more
CompanyRESMED INC
CIK0000943819
SEC File No.001-15317
Phone8587462400
Address9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA 92123